XML 54 R39.htm IDEA: XBRL DOCUMENT v3.22.1
Equity-Based Compensation (Tables)
12 Months Ended
Jan. 30, 2022
Share-based Payment Arrangement [Abstract]  
Schedule of outstanding Partnership Interests
A summary of the Partnership Interests is presented below (shares in thousands):
Number of SharesWeighted Average Benchmark Price
Outstanding on January 31, 20216,322 $6.92 
Granted406 18.00 
Forfeitures(58)8.46 
Repurchases(15)8.46 
Outstanding prior to Reorganization Transactions6,655 7.58 
Conversion4,690 
Outstanding on January 30, 2022
11,345 $— 
Number of SharesWeighted Average Benchmark Price
Non-vested at January 31, 20212,785 $7.01 
Granted406 18.00 
Forfeitures(58)8.46 
Repurchases(15)8.46 
Vested(114)7.25 
Non-vested prior to Reorganization Transactions3,004 8.44 
Conversion of non-vested awards2,018 — 
Non-vested following the Reorganization Transactions5,022 — 
Vested(1,966)— 
Non-vested at January 30, 2022
3,056 $— 
Schedule of non-vested Partnership Interests
Number of SharesWeighted Average Benchmark Price
Non-vested at January 31, 20212,785 $7.01 
Granted406 18.00 
Forfeitures(58)8.46 
Repurchases(15)8.46 
Vested(114)7.25 
Non-vested prior to Reorganization Transactions3,004 8.44 
Conversion of non-vested awards2,018 — 
Non-vested following the Reorganization Transactions5,022 — 
Vested(1,966)— 
Non-vested at January 30, 2022
3,056 $— 
Schedule of weighted-average valuation assumptions The fair value for these profits units was estimated by management, after considering a third-party valuation specialist’s assessment, at the date of grant based on the expected life of the profits units, using a Black-Scholes pricing model with the following weighted-average assumptions:
January 30, 2022January 31, 2021February 2, 2020
Risk-free interest rate0.78 %0.63 %2.13 %
Dividend yield— %— %— %
Expected volatility factor50 %50 %50 %
Discount for lack of marketability20 %26 %30 %
Expected life in years5.05.04.5
Schedule of stock appreciation rights
A summary of the stock appreciation rights is presented below (shares in thousands):
Number of SharesWeighted Average Benchmark Price
Outstanding on January 31, 2021
200 $10.00 
Granted100 18.00 
Outstanding prior to Reorganization Transactions300 12.66 
Conversion334 
Outstanding following the Reorganization Transactions634 5.00 
Forfeitures(53)8.52 
Outstanding on January 30, 2022
581 $4.67 
Number of SharesWeighted Average Benchmark Price
Non-vested at January 31, 2021105 $10.00 
Granted100 18.00 
Vested(20)10.00 
Non-vested prior to the Reorganization Transactions185 14.32 
Conversion of non-vested awards206 
Non-vested following the Reorganization Transactions391 6.09 
Vested(42)3.24 
Forfeitures(53)8.52 
Non-vested at January 30, 2022
296 $6.07 
The estimated fair value of the stock appreciation rights when granted was amortized to expense over the vesting or required service period. The fair value for these stock appreciation rights was estimated by management, after considering a third-party valuation specialist’s assessment, at the date of grant based on the expected life of the unit appreciation rights, using a Black-Scholes pricing model with the following weighted-average assumptions:
January 30, 2022February 2, 2020
Risk-free interest rate0.78 %2.13 %
Dividend yield— %— %
Expected volatility factor50 %50 %
Discount for lack of marketability20 %30 %
Expected life in years5.04.5